Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (341-350 of 496) with videos related to

Pageof 50
Sort By:
JAMA Network Open|February 24, 2023
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic SusceptibilityLauren M Hurwitz, Penelope M Webb, Susan J Jordan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 4, 2012
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genesBrooke L Fridley, Gregory D Jenkins, Ya-Yu Tsai, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
NMR metabolomic modelling of age and lifespan: a multi-cohort analysisChung-Ho E Lau, Maria Manou, Georgios Markozannes, et al.
Aging Cell|April 19, 2024
NMR metabolomic modeling of age and lifespan: A multicohort analysisChung-Ho E Lau, Maria Manou, Georgios Markozannes, et al.
European Journal of Epidemiology|September 22, 2020
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studiesFrancesmary Modugno, Zhuxuan Fu, Susan J Jordan, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Lancet (London, England)|May 15, 2021
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Research Square|August 30, 2023
Alcohol intake and endogenous sex hormones in women: meta-analysis of cohort studies and Mendelian randomizationSandar Tin Tin, Karl Smith-Byrne, Pietro Ferrari, et al.
Pageof 50

Showing results (341-350 of 496) with videos related to

Sort By:
Pageof 50
JAMA Network Open|February 24, 2023
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic SusceptibilityLauren M Hurwitz, Penelope M Webb, Susan J Jordan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 4, 2012
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genesBrooke L Fridley, Gregory D Jenkins, Ya-Yu Tsai, et al.
British Journal of Cancer|July 26, 2017
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Alistair J McGuire, Maria Raikou, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
NMR metabolomic modelling of age and lifespan: a multi-cohort analysisChung-Ho E Lau, Maria Manou, Georgios Markozannes, et al.
Aging Cell|April 19, 2024
NMR metabolomic modeling of age and lifespan: A multicohort analysisChung-Ho E Lau, Maria Manou, Georgios Markozannes, et al.
European Journal of Epidemiology|September 22, 2020
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studiesFrancesmary Modugno, Zhuxuan Fu, Susan J Jordan, et al.
The Lancet. Oncology|March 14, 2009
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, et al.
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
Lancet (London, England)|May 15, 2021
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Research Square|August 30, 2023
Alcohol intake and endogenous sex hormones in women: meta-analysis of cohort studies and Mendelian randomizationSandar Tin Tin, Karl Smith-Byrne, Pietro Ferrari, et al.
Pageof 50